Nelfinavir

Drug Profile

Nelfinavir

Alternative Names: AG 1343; LY 312857; Nelfinavir mesylate; Viracept

Latest Information Update: 15 Oct 2013

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Agouron Pharmaceuticals; Japan Tobacco
  • Developer Agouron Pharmaceuticals; Chugai Pharmaceutical; Japan Tobacco
  • Class Antiretrovirals; Isoquinolines
  • Mechanism of Action HIV protease inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Marketed HIV infections

Most Recent Events

  • 15 Mar 2016 Biomarkers information updated
  • 02 Dec 2011 Withdrawn for HIV infections in Switzerland (PO)
  • 01 Dec 2011 Withdrawn for HIV infections in European Union (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top